Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: Pooled analysis of placebo data from 3 randomized controlled trials

Conor P. Delaney, Anthony J. Senagore, Eugene R. Viscusi, Bruce G. Wolff, John Fort, Wei Du, Lee Techner, Bruce Wallin

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background: This analysis examines gastrointestinal recovery in patients who underwent bowel resection (BR) in 3 recent trials. Methods: Patients who underwent BR in the placebo groups of 3 randomized, double-blind, phase III, parallel-group, multicenter alvimopan efficacy trials were analyzed. Results: Most patients tolerated solid food and had a bowel movement by postoperative day 4. The majority of patients were discharged from the hospital by day 6, but 24.4% required a prolonged hospital stay or readmission. The incidence of nausea was highest on the day of surgery and decreased thereafter, whereas vomiting was uncommon on the day of surgery but increased slightly on postoperative days 1 to 6. The incidence of postoperative nasogastric tube insertion was highest (12%) on day 2. Conclusions: This analysis provides valuable clinical insight into gastrointestinal recovery after BR in a large homogenous patient population receiving multimodal care.

Original languageEnglish (US)
Pages (from-to)315-319
Number of pages5
JournalAmerican Journal of Surgery
Volume191
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Randomized Controlled Trials
Placebos
Morbidity
alvimopan
Ambulatory Surgical Procedures
Patient Readmission
Incidence
Nausea
Vomiting
Length of Stay
Food
Population

Keywords

  • Alvimopan
  • Bowel resection
  • Hospital discharge
  • Nausea
  • Postoperative ileus
  • Vomiting

ASJC Scopus subject areas

  • Surgery

Cite this

Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection : Pooled analysis of placebo data from 3 randomized controlled trials. / Delaney, Conor P.; Senagore, Anthony J.; Viscusi, Eugene R.; Wolff, Bruce G.; Fort, John; Du, Wei; Techner, Lee; Wallin, Bruce.

In: American Journal of Surgery, Vol. 191, No. 3, 03.2006, p. 315-319.

Research output: Contribution to journalArticle

Delaney, Conor P. ; Senagore, Anthony J. ; Viscusi, Eugene R. ; Wolff, Bruce G. ; Fort, John ; Du, Wei ; Techner, Lee ; Wallin, Bruce. / Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection : Pooled analysis of placebo data from 3 randomized controlled trials. In: American Journal of Surgery. 2006 ; Vol. 191, No. 3. pp. 315-319.
@article{93a6502014e94c27b3f1496b3721ee37,
title = "Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: Pooled analysis of placebo data from 3 randomized controlled trials",
abstract = "Background: This analysis examines gastrointestinal recovery in patients who underwent bowel resection (BR) in 3 recent trials. Methods: Patients who underwent BR in the placebo groups of 3 randomized, double-blind, phase III, parallel-group, multicenter alvimopan efficacy trials were analyzed. Results: Most patients tolerated solid food and had a bowel movement by postoperative day 4. The majority of patients were discharged from the hospital by day 6, but 24.4{\%} required a prolonged hospital stay or readmission. The incidence of nausea was highest on the day of surgery and decreased thereafter, whereas vomiting was uncommon on the day of surgery but increased slightly on postoperative days 1 to 6. The incidence of postoperative nasogastric tube insertion was highest (12{\%}) on day 2. Conclusions: This analysis provides valuable clinical insight into gastrointestinal recovery after BR in a large homogenous patient population receiving multimodal care.",
keywords = "Alvimopan, Bowel resection, Hospital discharge, Nausea, Postoperative ileus, Vomiting",
author = "Delaney, {Conor P.} and Senagore, {Anthony J.} and Viscusi, {Eugene R.} and Wolff, {Bruce G.} and John Fort and Wei Du and Lee Techner and Bruce Wallin",
year = "2006",
month = "3",
doi = "10.1016/j.amjsurg.2005.10.026",
language = "English (US)",
volume = "191",
pages = "315--319",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection

T2 - Pooled analysis of placebo data from 3 randomized controlled trials

AU - Delaney, Conor P.

AU - Senagore, Anthony J.

AU - Viscusi, Eugene R.

AU - Wolff, Bruce G.

AU - Fort, John

AU - Du, Wei

AU - Techner, Lee

AU - Wallin, Bruce

PY - 2006/3

Y1 - 2006/3

N2 - Background: This analysis examines gastrointestinal recovery in patients who underwent bowel resection (BR) in 3 recent trials. Methods: Patients who underwent BR in the placebo groups of 3 randomized, double-blind, phase III, parallel-group, multicenter alvimopan efficacy trials were analyzed. Results: Most patients tolerated solid food and had a bowel movement by postoperative day 4. The majority of patients were discharged from the hospital by day 6, but 24.4% required a prolonged hospital stay or readmission. The incidence of nausea was highest on the day of surgery and decreased thereafter, whereas vomiting was uncommon on the day of surgery but increased slightly on postoperative days 1 to 6. The incidence of postoperative nasogastric tube insertion was highest (12%) on day 2. Conclusions: This analysis provides valuable clinical insight into gastrointestinal recovery after BR in a large homogenous patient population receiving multimodal care.

AB - Background: This analysis examines gastrointestinal recovery in patients who underwent bowel resection (BR) in 3 recent trials. Methods: Patients who underwent BR in the placebo groups of 3 randomized, double-blind, phase III, parallel-group, multicenter alvimopan efficacy trials were analyzed. Results: Most patients tolerated solid food and had a bowel movement by postoperative day 4. The majority of patients were discharged from the hospital by day 6, but 24.4% required a prolonged hospital stay or readmission. The incidence of nausea was highest on the day of surgery and decreased thereafter, whereas vomiting was uncommon on the day of surgery but increased slightly on postoperative days 1 to 6. The incidence of postoperative nasogastric tube insertion was highest (12%) on day 2. Conclusions: This analysis provides valuable clinical insight into gastrointestinal recovery after BR in a large homogenous patient population receiving multimodal care.

KW - Alvimopan

KW - Bowel resection

KW - Hospital discharge

KW - Nausea

KW - Postoperative ileus

KW - Vomiting

UR - http://www.scopus.com/inward/record.url?scp=33144481857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33144481857&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2005.10.026

DO - 10.1016/j.amjsurg.2005.10.026

M3 - Article

C2 - 16490538

AN - SCOPUS:33144481857

VL - 191

SP - 315

EP - 319

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 3

ER -